UK drugmaker in China bribery probe

GlaxoSmithKline's British and Chinese executives accused of paying off health institutions to use their pricey products.

    Police in China have completed an investigation into a suspected bribery case involving the multinational pharmaceutical company GlaxoSmithKline (GSK) and handed it over to prosecutors on Wednesday.

    After an almost year-long investigation, police alleged that William Mark Reilly, a British national and executive of GSK China, and two Chinese executives, Zhang Guowei and Zhao Hongyan, bribed Chinese hospitals, doctors and health institutions, to use their products.

    The drugmaker GSK China used illegal means to maximise profit, its former employees alleged.

    Al Jazeera's Tim Friend reports from London.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Interactive: Take a tour through divided Jerusalem

    Interactive: Take a tour through divided Jerusalem

    Take a tour through East and West Jerusalem to see the difference in quality of life for Israelis and Palestinians.

    Stories from the sex trade

    Stories from the sex trade

    Dutch sex workers, pimps and johns share their stories.

    Inside the world of India's booming fertility industry

    Inside the world of India's booming fertility industry

    As the stigma associated with being childless persists, some elderly women in India risk it all to become mothers.